APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lung Surfactants

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lung Surfactants Market Outlook and Growth Opportunities 2026

2 January 2026191 pages

Choose your research edition.

Industry ResearchLung Surfactants Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Lung Surfactants Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Lung Surfactants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lung Surfactants Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Lung Surfactants Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Lung Surfactants market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lung Surfactants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lung Surfactants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lung Surfactants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lung Surfactants market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lung Surfactants market include Aviva Systems Biology Corporation, Chiesi Farmaceutici, Lyomark Pharma, ONY Biotech, Windtree Therapeutics and AbbVie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lung Surfactants market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lung Surfactants and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lung Surfactants sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lung Surfactants market size, projected growth trends, production technologies, key applications, and end-use industries.

Lung Surfactants Segment by Company

Aviva Systems Biology Corporation

Chiesi Farmaceutici

Lyomark Pharma

ONY Biotech

Windtree Therapeutics

AbbVie

Lung Surfactants Segment by Type

Intratracheal

Injectable

Lung Surfactants Segment by Application

Special Clinic

Hospital

Recovery Center

Lung Surfactants Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Lung Surfactants status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Lung Surfactants market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lung Surfactants significant trends, drivers, influence factors in global and regions.

6. To analyze Lung Surfactants competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lung Surfactants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lung Surfactants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lung Surfactants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lung Surfactants market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lung Surfactants industry.

Chapter 3: Detailed analysis of Lung Surfactants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Lung Surfactants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Lung Surfactants in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lung Surfactants Industry Trends Table 2. Lung Surfactants Industry Drivers Table 3. Lung Surfactants Industry Opportunities and Challenges Table 4. Lung Surfactants Industry Restraints Table 5. Global Lung Surfactants Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lung Surfactants Revenue Share by Company (2021-2026) Table 7. Global Lung Surfactants Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Lung Surfactants Sales Volume Share by Company (2021-2026) Table 9. Global Lung Surfactants Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Lung Surfactants Company Ranking, (2024-2026) & (USD Million) Table 11. Global Lung Surfactants Key Company Manufacturing Base & Headquarters Table 12. Global Lung Surfactants Company, Product Type & Application Table 13. Global Lung Surfactants Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Lung Surfactants by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Intratracheal Table 18. Significant Companies of Injectable Table 19. Global Lung Surfactants Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Lung Surfactants Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Lung Surfactants Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Lung Surfactants Sales Volume Share by Type (2021-2026) Table 23. Global Lung Surfactants Sales Volume Share by Type (2027-2032) Table 24. Global Lung Surfactants Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lung Surfactants Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Lung Surfactants Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Lung Surfactants Sales Value Share by Type (2021-2026) Table 28. Global Lung Surfactants Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Special Clinic Table 30. Significant Companies of Hospital Table 31. Significant Companies of Recovery Center Table 32. Global Lung Surfactants Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Lung Surfactants Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Lung Surfactants Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Lung Surfactants Sales Volume Share by Application (2021-2026) Table 36. Global Lung Surfactants Sales Volume Share by Application (2027-2032) Table 37. Global Lung Surfactants Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Lung Surfactants Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Lung Surfactants Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Lung Surfactants Sales Value Share by Application (2021-2026) Table 41. Global Lung Surfactants Sales Value Share by Application (2027-2032) Table 42. Global Lung Surfactants Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Lung Surfactants Sales by Region (2021-2026) & (K Units) Table 44. Global Lung Surfactants Sales Market Share by Region (2021-2026) Table 45. Global Lung Surfactants Sales by Region (2027-2032) & (K Units) Table 46. Global Lung Surfactants Sales Market Share by Region (2027-2032) Table 47. Global Lung Surfactants Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Lung Surfactants Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Lung Surfactants Sales Value Share by Region (2021-2026) Table 50. Global Lung Surfactants Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Lung Surfactants Sales Value Share by Region (2027-2032) Table 52. Global Lung Surfactants Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Lung Surfactants Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Lung Surfactants Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Lung Surfactants Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Lung Surfactants Sales by Country (2021-2026) & (K Units) Table 57. Global Lung Surfactants Sales Market Share by Country (2021-2026) Table 58. Global Lung Surfactants Sales by Country (2027-2032) & (K Units) Table 59. Global Lung Surfactants Sales Market Share by Country (2027-2032) Table 60. Global Lung Surfactants Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Lung Surfactants Sales Value Market Share by Country (2021-2026) Table 62. Global Lung Surfactants Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Lung Surfactants Sales Value Market Share by Country (2027-2032) Table 64. Aviva Systems Biology Corporation Company Information Table 65. Aviva Systems Biology Corporation Business Overview Table 66. Aviva Systems Biology Corporation Lung Surfactants Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Aviva Systems Biology Corporation Lung Surfactants Product Portfolio Table 68. Aviva Systems Biology Corporation Recent Development Table 69. Chiesi Farmaceutici Company Information Table 70. Chiesi Farmaceutici Business Overview Table 71. Chiesi Farmaceutici Lung Surfactants Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Chiesi Farmaceutici Lung Surfactants Product Portfolio Table 73. Chiesi Farmaceutici Recent Development Table 74. Lyomark Pharma Company Information Table 75. Lyomark Pharma Business Overview Table 76. Lyomark Pharma Lung Surfactants Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Lyomark Pharma Lung Surfactants Product Portfolio Table 78. Lyomark Pharma Recent Development Table 79. ONY Biotech Company Information Table 80. ONY Biotech Business Overview Table 81. ONY Biotech Lung Surfactants Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. ONY Biotech Lung Surfactants Product Portfolio Table 83. ONY Biotech Recent Development Table 84. Windtree Therapeutics Company Information Table 85. Windtree Therapeutics Business Overview Table 86. Windtree Therapeutics Lung Surfactants Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Windtree Therapeutics Lung Surfactants Product Portfolio Table 88. Windtree Therapeutics Recent Development Table 89. AbbVie Company Information Table 90. AbbVie Business Overview Table 91. AbbVie Lung Surfactants Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. AbbVie Lung Surfactants Product Portfolio Table 93. AbbVie Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Lung Surfactants Distributors List Table 97. Lung Surfactants Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Lung Surfactants Product Image Figure 2. Global Lung Surfactants Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lung Surfactants Sales Value (2021-2032) & (US$ Million) Figure 4. Global Lung Surfactants Sales (2021-2032) & (K Units) Figure 5. Global Lung Surfactants Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Lung Surfactants Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Intratracheal Image Figure 10. Injectable Image Figure 11. Global Lung Surfactants Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Lung Surfactants Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Lung Surfactants Sales Volume Share by Type (2021-2032) Figure 14. Global Lung Surfactants Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Lung Surfactants Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Lung Surfactants Sales Value Share by Type (2021-2032) Figure 17. Special Clinic Image Figure 18. Hospital Image Figure 19. Recovery Center Image Figure 20. Global Lung Surfactants Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Lung Surfactants Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Lung Surfactants Sales Volume Share by Application (2021-2032) Figure 23. Global Lung Surfactants Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Lung Surfactants Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Lung Surfactants Sales Value Share by Application (2021-2032) Figure 26. Global Lung Surfactants Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Lung Surfactants Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Lung Surfactants Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Lung Surfactants Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Lung Surfactants Sales Value (2021-2032) & (US$ Million) Figure 31. North America Lung Surfactants Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Lung Surfactants Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Lung Surfactants Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Lung Surfactants Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Lung Surfactants Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Lung Surfactants Sales Value (2021-2032) & (US$ Million) Figure 37. South America Lung Surfactants Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Lung Surfactants Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Lung Surfactants Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Lung Surfactants Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Lung Surfactants Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Lung Surfactants Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Lung Surfactants Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Lung Surfactants Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Intratracheal
  • Injectable
Applications
  • Special Clinic
  • Hospital
  • Recovery Center
Companies covered
  • Aviva Systems Biology Corporation
  • Chiesi Farmaceutici
  • Lyomark Pharma
  • ONY Biotech
  • Windtree Therapeutics
  • AbbVie

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lung Surfactants Sales Value (2021-2032)
  4. 1.2.2 Global Lung Surfactants Sales Volume (2021-2032)
  5. 1.2.3 Global Lung Surfactants Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Lung Surfactants Market Dynamics
  1. 2.1 Lung Surfactants Industry Trends
  2. 2.2 Lung Surfactants Industry Drivers
  3. 2.3 Lung Surfactants Industry Opportunities and Challenges
  4. 2.4 Lung Surfactants Industry Restraints
3 Lung Surfactants Market by Company
  1. 3.1 Global Lung Surfactants Company Revenue Ranking in 2025
  2. 3.2 Global Lung Surfactants Revenue by Company (2021-2026)
  3. 3.3 Global Lung Surfactants Sales Volume by Company (2021-2026)
  4. 3.4 Global Lung Surfactants Average Price by Company (2021-2026)
  5. 3.5 Global Lung Surfactants Company Ranking (2024-2026)
  6. 3.6 Global Lung Surfactants Company Manufacturing Base and Headquarters
  7. 3.7 Global Lung Surfactants Company Product Type and Application
  8. 3.8 Global Lung Surfactants Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Lung Surfactants Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Lung Surfactants Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Lung Surfactants Market by Type
  1. 4.1 Lung Surfactants Type Introduction
  2. 4.1.1 Intratracheal
  3. 4.1.2 Injectable
  4. 4.2 Global Lung Surfactants Sales Volume by Type
  5. 4.2.1 Global Lung Surfactants Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lung Surfactants Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Lung Surfactants Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Lung Surfactants Sales Value by Type
  9. 4.3.1 Global Lung Surfactants Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lung Surfactants Sales Value by Type (2021-2032)
  11. 4.3.3 Global Lung Surfactants Sales Value Share by Type (2021-2032)
5 Lung Surfactants Market by Application
  1. 5.1 Lung Surfactants Application Introduction
  2. 5.1.1 Special Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Recovery Center
  5. 5.2 Global Lung Surfactants Sales Volume by Application
  6. 5.2.1 Global Lung Surfactants Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lung Surfactants Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Lung Surfactants Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Lung Surfactants Sales Value by Application
  10. 5.3.1 Global Lung Surfactants Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lung Surfactants Sales Value by Application (2021-2032)
  12. 5.3.3 Global Lung Surfactants Sales Value Share by Application (2021-2032)
6 Lung Surfactants Regional Sales and Value Analysis
  1. 6.1 Global Lung Surfactants Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lung Surfactants Sales by Region (2021-2032)
  3. 6.2.1 Global Lung Surfactants Sales by Region: 2021-2026
  4. 6.2.2 Global Lung Surfactants Sales by Region (2027-2032)
  5. 6.3 Global Lung Surfactants Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Lung Surfactants Sales Value by Region (2021-2032)
  7. 6.4.1 Global Lung Surfactants Sales Value by Region: 2021-2026
  8. 6.4.2 Global Lung Surfactants Sales Value by Region (2027-2032)
  9. 6.5 Global Lung Surfactants Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Lung Surfactants Sales Value (2021-2032)
  12. 6.6.2 North America Lung Surfactants Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Lung Surfactants Sales Value (2021-2032)
  15. 6.7.2 Europe Lung Surfactants Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Lung Surfactants Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Lung Surfactants Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Lung Surfactants Sales Value (2021-2032)
  21. 6.9.2 South America Lung Surfactants Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Lung Surfactants Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Lung Surfactants Sales Value Share by Country, 2025 VS 2032
7 Lung Surfactants Country-level Sales and Value Analysis
  1. 7.1 Global Lung Surfactants Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lung Surfactants Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Lung Surfactants Sales by Country (2021-2032)
  4. 7.3.1 Global Lung Surfactants Sales by Country (2021-2026)
  5. 7.3.2 Global Lung Surfactants Sales by Country (2027-2032)
  6. 7.4 Global Lung Surfactants Sales Value by Country (2021-2032)
  7. 7.4.1 Global Lung Surfactants Sales Value by Country (2021-2026)
  8. 7.4.2 Global Lung Surfactants Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Lung Surfactants Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Lung Surfactants Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Lung Surfactants Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Lung Surfactants Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Lung Surfactants Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Lung Surfactants Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Lung Surfactants Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Lung Surfactants Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Lung Surfactants Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Lung Surfactants Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Lung Surfactants Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Lung Surfactants Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Lung Surfactants Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Lung Surfactants Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Lung Surfactants Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Lung Surfactants Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Lung Surfactants Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Lung Surfactants Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Lung Surfactants Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Lung Surfactants Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Lung Surfactants Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Lung Surfactants Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Lung Surfactants Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Lung Surfactants Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Lung Surfactants Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Lung Surfactants Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Lung Surfactants Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Lung Surfactants Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Lung Surfactants Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Lung Surfactants Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Lung Surfactants Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aviva Systems Biology Corporation
  2. 8.1.1 Aviva Systems Biology Corporation Company Information
  3. 8.1.2 Aviva Systems Biology Corporation Business Overview
  4. 8.1.3 Aviva Systems Biology Corporation Lung Surfactants Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Aviva Systems Biology Corporation Lung Surfactants Product Portfolio
  6. 8.1.5 Aviva Systems Biology Corporation Recent Developments
  7. 8.2 Chiesi Farmaceutici
  8. 8.2.1 Chiesi Farmaceutici Company Information
  9. 8.2.2 Chiesi Farmaceutici Business Overview
  10. 8.2.3 Chiesi Farmaceutici Lung Surfactants Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Chiesi Farmaceutici Lung Surfactants Product Portfolio
  12. 8.2.5 Chiesi Farmaceutici Recent Developments
  13. 8.3 Lyomark Pharma
  14. 8.3.1 Lyomark Pharma Company Information
  15. 8.3.2 Lyomark Pharma Business Overview
  16. 8.3.3 Lyomark Pharma Lung Surfactants Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Lyomark Pharma Lung Surfactants Product Portfolio
  18. 8.3.5 Lyomark Pharma Recent Developments
  19. 8.4 ONY Biotech
  20. 8.4.1 ONY Biotech Company Information
  21. 8.4.2 ONY Biotech Business Overview
  22. 8.4.3 ONY Biotech Lung Surfactants Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 ONY Biotech Lung Surfactants Product Portfolio
  24. 8.4.5 ONY Biotech Recent Developments
  25. 8.5 Windtree Therapeutics
  26. 8.5.1 Windtree Therapeutics Company Information
  27. 8.5.2 Windtree Therapeutics Business Overview
  28. 8.5.3 Windtree Therapeutics Lung Surfactants Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Windtree Therapeutics Lung Surfactants Product Portfolio
  30. 8.5.5 Windtree Therapeutics Recent Developments
  31. 8.6 AbbVie
  32. 8.6.1 AbbVie Company Information
  33. 8.6.2 AbbVie Business Overview
  34. 8.6.3 AbbVie Lung Surfactants Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 AbbVie Lung Surfactants Product Portfolio
  36. 8.6.5 AbbVie Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lung Surfactants Value Chain Analysis
  2. 9.1.1 Lung Surfactants Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lung Surfactants Sales Mode & Process
  6. 9.2 Lung Surfactants Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lung Surfactants Distributors
  9. 9.2.3 Lung Surfactants Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst